Recap of ACR

• Date :
• 3    
  0

Biosimilars

• Date :
• 2    
  0

FDA Update

• Date :
• 2    
  0

What's Happening at ACR 2019

• Date :
• 1    
  0

Women in Rheumatology

• Date :
• 1    
  0

Drug Levels Associated with Lupus Flares

• Date :
• 1    
  0

Hydralazine-Associated Vasculitis

• Date :
• 1    
  0

Rituximab-Associated Hypogammaglobulinemia Rates

• Date :
• 0    
  0

Inflammatory Back Pain in axSpA

• Date :
• 0    
  0

Use of TNF Inhibitors

• Date :
• 0    
  0

ANCA-Associated Vasculitis Guidelines

• Date :
• 0    
  0

SELECT-MONOTHERAPY Trial

• Date :
• 0    
  0

Shoulder MRI for PMR

• Date :
• 0    
  0

Draft Guidelines for Arteritis

• Date :
• 0    
  0

Highlights of AS, Psoriatic Arthritis Studies

• Date :
• 0    
  0

Primer in Comorbidities in Lupus

• Date :
• 0    
  0

2019 Guidelines for the Management of Giant Cell Arteritis

• Date :
• 0    
  0

MTX Withdraw after Starting JAK Inhibitors

• Date :
• 0    
  0

The Great Debate

• Date :
• 0    
  0

The Rheumatology Podcasters

• Date :
• 0    
  0

Myosin Regulation May Contribute to Anti-TNF Therapy Response

• Date :
• 0    
  0

Treatment to Reduce Inflammation During Gout Flares

• Date :
• 0    
  0

Inflammatory Arthritis Persists After Immunotherapy Cessation

• Date :
• 0    
  0

ANCA-Associated Vasculitis Highlights

• Date :
• 0    
  0

IgG4 Related Disease

• Date :
• 0    
  0

MACE + VTE Across Upadacitinib Studies in RA Patients

• Date :
• 0    
  0

Psoriatic Arthritis and Guselkumab

• Date :
• 0    
  0

Emapalumab Treatment in Macrophage Activation Syndrome

• Date :
• 0    
  0

PANLAR Recommendations on Imaging Studies for Gout

• Date :
• 0    
  0

Fibromyalgia Treatments

• Date :
• 0    
  0

Antimalarials in RA

• Date :
• 0    
  0

Legislative Update

• Date :
• 0    
  0

Infection Prevention and Immunosuppression

• Date :
• 0    
  0

Overview of the Klemperer Lecture

• Date :
• 0    
  0

Two Particular PANLAR Gout Imaging Recommendations

• Date :
• 0    
  0

Gender Differences in AS

• Date :
• 0    
  0

Will Reduction of RF affect Erosions in RA

• Date :
• 0    
  0

Upadacitinib in RA

• Date :
• 0    
  0

Dr. Kanika Monga Interviews Dr. John Reveille

• Date :
• 0    
  0

Clinical Infection Risk and Safety Profiles in RA

• Date :
• 0    
  0

Macrophage Activation Syndrome

• Date :
• 0    
  0

Vasculitis Pearls

• Date :
• 0    
  0

New Treatments for Axial Spondyloarthritis

• Date :
• 0    
  0

Romosozumab and Patients with Chronic Kidney Disease

• Date :
• 0    
  0

Rheumatology Pearls

• Date :
• 0    
  0

Pearls of IgG4 Related Disease

• Date :
• 0    
  0

SJIA-associated ILD

• Date :
• 0    
  0

Use of MRI in GCA

• Date :
• 0    
  0

Tofacitinib as Monotherapy Following MTX Withdrawal in PsA

• Date :
• 0    
  0

Lupus Pearls

• Date :
• 0    
  0

Panel Presentation: Gout

• Date :
• 0    
  0

Ixekizimab Withdrawal in PSA

• Date :
• 0    
  0

Pearls for Evaluating PSA patients

• Date :
• 0    
  0

High Dose Influenza Vaccine Under Age 65

• Date :
• 0    
  0

Panel Presentation: Psoriatic Arthritis

• Date :
• 0    
  0

Non-radiographic axSpA

• Date :
• 0    
  0

Welcome to ACR 2019

• Date :
• 0    
  0

RheumNow Podcast –Favorites of ACR 2019

• Date :
• 0    
  0

Patient Beliefs on Methotrexate

• Date :
• 0    
  0

Panel Presentation: Spondyloarthritis

• Date :
• 0    
  0

Viral Reactivation in Vaccination

• Date :
• 0    
  0

The Risk RA Prospective Study

• Date :
• 0    
  0

Panel Presentation: The X Factor

• Date :
• 0    
  0

Social Media Professionalism

• Date :
• 0    
  0

Studies on the Changing Face of RA

• Date :
• 0    
  0

Domain Strategy and Treatment in Psoriatic Arthritis

• Date :
• 0    
  0

Depression in Psoriatic Arthritis

• Date :
• 0    
  0

Panel Presentation: Rheumatoid Arthritis

• Date :
• 0    
  0

Panel Presentation: Understanding iRAEs from Immune Checkpoint Inhibitors

• Date :
• 0    
  0

Safety of Methotrexate (The CIRT Trial)

• Date :
• 0    
  0

Cryoglobulinaemic Vasculitis Related to Hepatitis C

• Date :
• 0    
  0

Bad to the Bone

• Date :
• 0    
  0

Methotrexate and Prednisone for Hand OA

• Date :
• 0    
  0

Gout Studies at ACR

• Date :
• 0    
  0

Subcutaneous Biosimilar

• Date :
• 0    
  0

Overview of Several Gout Studies

• Date :
• 0    
  0

Comparison of Ixekizumab and Adalimumab in PsA

• Date :
• 0    
  0

TULIP Trials in Lupus

• Date :
• 0    
  0

Social Media for the Medical Professional

• Date :
• 0    
  0

WCO-IOF-ESCEO 2025

• Date :
• 2829    
  0

Congrès de la Société Française d'Arthroscopie - SFA 2024

• Date :
• 3064    
  0

10th Annual MENA International Orthopaedics Congress - MENA 2024

• Date :
• 2254    
  0

26th Asia-Pacific League of Associations for Rheumatology Congress - APLAR 2024

• Date :
• 7025    
  0

Congrès Européen de l'Européen de la Société d'Orthopédie et Traumatologie de l'Est - SOTEST 2024

• Date :
• 14286    
  0